LLY vs SYK
By Alex · Tickerpine
Eli Lilly and Company vs Stryker Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | SYK |
|---|---|---|
| Price | $1,184.78 | $275.31 |
| Market cap | $1.06T | $105.60B |
| P/E ratio | 39.7 | 28.2 |
| ROE | 102.29% | 16.51% |
| Profit margin | 33.53% | 14.43% |
| Revenue growth | 47.70% | 9.40% |
| Dividend yield | 0.58% | 1.28% |
| Beta | 0.50 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs SYK in plain English
- LLY is the bigger company — about 10.0× the market cap of SYK.
- SYK is cheaper on earnings (P/E 28.2 vs 39.7).
- LLY earns a higher return on equity (102% vs 17%).
- LLY is growing revenue faster (48% vs 9%).
- SYK has the higher dividend yield (1.28% vs 0.58%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
SYK return calculator
See what $1,000 in Stryker Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.